You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The test is the first automated molecular test for assessing HBV treatment to receive FDA approval, Abbott said.
The FDA approved an additional intended use for Roche's licensed Cobas TaqScreen MPX nucleic acid test to screen donated source plasma.
The agreement covers systems for HIV and hepatitis B management.
The companies have now “put together the final project plan, budgets, and agreements” for the HBV effort, according to Benitec’s CEO.
In Brief This Week is a Friday column containing news items that our readers may have missed during the week.
Chronix Biomedical, Rosetta Genomics, National Institute of General Medical Sciences, National Center for Genome Resources, Beyond Batten Disease Research Foundation, and more ...
Chronix Biomedical said that the current study confirms its previous research showing that CNAs can identify the presence of certain diseases in blood samples months to years before clinical symptoms appear.
The Athens, Ohio-based firm licensed novel yeast-based virus cloning technology that will be used for HIV pharmacogenomics and other disease areas.
Cerenis, Montreal Heart Institute, UVA, Ortho Clinical, Mirna, UCSF, Case Western, Diagnostic Hybrids, iBridge Network, Ben Franklin Tech Partners, and more…
Public health experts call for a transparent COVID-19 vaccine approval process in a letter; the Food and Drug Administration commissioner assures science-based approval.
The Verge reports that new gene-naming guidelines aim in part to avoid Excel-related name change confusion.
In Nature this week: tuatara genome sequence aids in understanding amniote evolution, and more.
According to the Guardian, UK virologists say in a letter to officials that their expertise has been pushed aside in COVID-19 response plans.